
Wing Walking
A challenge event like no other! We are now offering wing walking experiences at various locations, in aid of Retina UK.
Search results
A challenge event like no other! We are now offering wing walking experiences at various locations, in aid of Retina UK.
May is National Walking Month! Are you ready to join #TeamRetinaUK in May for our daily 5K challenge? Your support will allow us to continue supporting those who are living with inherited sight loss.
Come together for Retina UK Day on Thursday, 9 October 2025 and help us raise awareness and funds for those who are living with inherited sight loss - during our 50th anniversary year.
May is National Walking Month! Are you ready to join #TeamRetinaUK in May for our daily 5K challenge? Your support will allow us to continue supporting those who are living with inherited sight loss.
A research project funded by Retina UK helped pave the way to a new gene therapy that has recently produced encouraging results in two young people with achromatopsia, a condition that causes complete colour-blindness and poor overall vision from birth.
X-linked inheritance means that the faulty gene is located on the X chromosome, the larger of the two sex chromosomes.
Beacon Therapeutics announced positive results from their phase 2 gene therapy trial for X-linked retinitis pigmentosa (XLRP) caused by mutations in the RPGR gene.
It was previously believed that female carriers of X-linked inherited retinal diseases (IRDs) like X-linked retinitis pigmentosa (RP and Choroideremia) remained unaffected by sight loss.
UK researchers have discovered that passing a weak electrical current between electrodes on a person’s scalp may lead to a reduction in frequency of the visual hallucinations experienced by some people living with sight loss.